Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Whittington

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Proceedings of Spie--The International Society for Optical Engineering|July 7, 2015
<i>In vivo</i> determination of the absorption and scattering spectra of the human prostate during photodynamic therapyJarod C Finlay, Timothy C Zhu, Andreea Dimofte, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2002
Using PSA, biopsy Gleason score, clinical stage, and the percentage of positive biopsies to identify optimal candidates for prostate-only radiation therapyMarshal E Lieberfarb, Delray Schultz, Richard Whittington, et al.
Urology|November 16, 2005
Impact of the percentage of positive biopsy cores on the further stratification of primary grade 3 and grade 4 Gleason score 7 tumors in radical prostatectomy patientsManish A Vira, John E Tomaszewski, Wei-Ting Hwang, et al.
International Journal of Nursing Studies|April 23, 2019
Minimising the use of physical restraint in acute mental health services: The outcome of a restraint reduction programme ('REsTRAIN YOURSELF')Joy Duxbury, John Baker, Soo Downe, et al.
The Journal of Urology|April 17, 2002
Lower prostate specific antigen outcome than expected following radical prostatectomy in patients with high grade prostate and a prostatic specific antigen level of 4 ng/ml. Or lessAnthony V D'Amico, Ming-Hui Chen, S Bruce Malkowicz, et al.
Medicine, Science, and the Law|April 16, 2019
International variations in mental-health law regulating involuntary commitment of psychiatric patients as measured by the Mental Health Legislation Attitudes ScaleIrina Georgieva, Richard Whittington, Christian Lauvrud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2002
Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostateChaundre K Cross, Delray Shultz, S Bruce Malkowicz, et al.
Cancer|April 9, 2005
The impact of a delay in initiating radiation therapy on prostate-specific antigen outcome for patients with clinically localized prostate carcinomaPaul L Nguyen, Richard Whittington, Sophia Koo, et al.
Fish & Shellfish Immunology|February 26, 2015
Resistance of Black-lip learl oyster, Pinctada margaritifera, to infection by Ostreid herpes virus 1μvar under experimental challenge may be mediated by humoral antiviral activityTerence L S Tan, Ika Paul-Pont, Olivia M Evans, et al.
The Oncologist|May 1, 2015
Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204Jerome C Landry, Yang Feng, Roshan S Prabhu, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Proceedings of Spie--The International Society for Optical Engineering|July 7, 2015
<i>In vivo</i> determination of the absorption and scattering spectra of the human prostate during photodynamic therapyJarod C Finlay, Timothy C Zhu, Andreea Dimofte, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2002
Using PSA, biopsy Gleason score, clinical stage, and the percentage of positive biopsies to identify optimal candidates for prostate-only radiation therapyMarshal E Lieberfarb, Delray Schultz, Richard Whittington, et al.
Urology|November 16, 2005
Impact of the percentage of positive biopsy cores on the further stratification of primary grade 3 and grade 4 Gleason score 7 tumors in radical prostatectomy patientsManish A Vira, John E Tomaszewski, Wei-Ting Hwang, et al.
International Journal of Nursing Studies|April 23, 2019
Minimising the use of physical restraint in acute mental health services: The outcome of a restraint reduction programme ('REsTRAIN YOURSELF')Joy Duxbury, John Baker, Soo Downe, et al.
The Journal of Urology|April 17, 2002
Lower prostate specific antigen outcome than expected following radical prostatectomy in patients with high grade prostate and a prostatic specific antigen level of 4 ng/ml. Or lessAnthony V D'Amico, Ming-Hui Chen, S Bruce Malkowicz, et al.
Medicine, Science, and the Law|April 16, 2019
International variations in mental-health law regulating involuntary commitment of psychiatric patients as measured by the Mental Health Legislation Attitudes ScaleIrina Georgieva, Richard Whittington, Christian Lauvrud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2002
Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostateChaundre K Cross, Delray Shultz, S Bruce Malkowicz, et al.
Cancer|April 9, 2005
The impact of a delay in initiating radiation therapy on prostate-specific antigen outcome for patients with clinically localized prostate carcinomaPaul L Nguyen, Richard Whittington, Sophia Koo, et al.
Fish & Shellfish Immunology|February 26, 2015
Resistance of Black-lip learl oyster, Pinctada margaritifera, to infection by Ostreid herpes virus 1μvar under experimental challenge may be mediated by humoral antiviral activityTerence L S Tan, Ika Paul-Pont, Olivia M Evans, et al.
The Oncologist|May 1, 2015
Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204Jerome C Landry, Yang Feng, Roshan S Prabhu, et al.
Pageof 11